AR228256A1 - Procedimiento para la elaboracion de nuevos compuestos de 2-(pirimidinilamino)-1,3-diaza-2-cicloalqueno - Google Patents
Procedimiento para la elaboracion de nuevos compuestos de 2-(pirimidinilamino)-1,3-diaza-2-cicloalquenoInfo
- Publication number
- AR228256A1 AR228256A1 AR281109A AR28110980A AR228256A1 AR 228256 A1 AR228256 A1 AR 228256A1 AR 281109 A AR281109 A AR 281109A AR 28110980 A AR28110980 A AR 28110980A AR 228256 A1 AR228256 A1 AR 228256A1
- Authority
- AR
- Argentina
- Prior art keywords
- pirimidinilamino
- cicloalqueno
- diaza
- elaboration
- procedure
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/42—One nitrogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/47—One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/48—Two nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/52—Two oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/52—Two oxygen atoms
- C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
- C07D239/545—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cardiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Heart & Thoracic Surgery (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH466979 | 1979-05-18 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR228256A1 true AR228256A1 (es) | 1983-02-15 |
Family
ID=4280399
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AR281109A AR228256A1 (es) | 1979-05-18 | 1980-05-19 | Procedimiento para la elaboracion de nuevos compuestos de 2-(pirimidinilamino)-1,3-diaza-2-cicloalqueno |
Country Status (21)
| Country | Link |
|---|---|
| EP (1) | EP0019811A1 (es) |
| JP (1) | JPS55154971A (es) |
| KR (1) | KR830002757A (es) |
| AR (1) | AR228256A1 (es) |
| AU (1) | AU5848480A (es) |
| DD (1) | DD150609A5 (es) |
| DK (1) | DK214480A (es) |
| ES (1) | ES491514A0 (es) |
| FI (1) | FI801600A7 (es) |
| GB (1) | GB2052487B (es) |
| GR (1) | GR68453B (es) |
| IE (1) | IE49803B1 (es) |
| IL (1) | IL60086A (es) |
| MA (1) | MA18829A1 (es) |
| NO (1) | NO801469L (es) |
| NZ (1) | NZ193730A (es) |
| OA (1) | OA06533A (es) |
| PL (1) | PL224313A1 (es) |
| PT (1) | PT71251A (es) |
| ZA (1) | ZA802909B (es) |
| ZW (1) | ZW11880A1 (es) |
Families Citing this family (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4507146A (en) * | 1982-12-28 | 1985-03-26 | Ciba-Geigy Corporation | 2,4-Diamino-6-halo-5-trifluoromethylpyrimidines having herbicidal activity |
| DE3829469A1 (de) * | 1988-08-31 | 1990-03-01 | Bayer Ag | Verfahren zur herstellung von substituierten n-azinyl-n'-sulfonyl-isothioharnstoffen und n-azinyl-iminodithiokohlensaeure-s,s-diester als zwischenprodukte zu ihrer herstellung |
| EP0954316A4 (en) * | 1997-09-03 | 2002-02-13 | Lilly Co Eli | PYRIMIDINE DERIVATIVES |
| US6660731B2 (en) | 2000-09-15 | 2003-12-09 | Vertex Pharmaceuticals Incorporated | Pyrazole compounds useful as protein kinase inhibitors |
| EP1317450B1 (en) | 2000-09-15 | 2006-11-22 | Vertex Pharmaceuticals Incorporated | Pyrazole compounds useful as protein kinase inhibitors |
| US7473691B2 (en) | 2000-09-15 | 2009-01-06 | Vertex Pharmaceuticals Incorporated | Pyrazole compounds useful as protein kinase inhibitors |
| CA2432222C (en) | 2000-12-21 | 2008-07-29 | Vertex Pharmaceuticals Incorporated | Pyrazole compounds useful as protein kinase inhibitors |
| EP2140862A3 (en) * | 2001-01-31 | 2010-02-17 | H.Lundbeck A/S | Use of GAL 3 receptor antagonists for the treatment of depression and /or anxiety and compounds useful in such methods |
| SI1483247T1 (sl) | 2002-03-13 | 2009-12-31 | Euro Celtique Sa | Arilno substituirani pirimidini in njihova uporaba |
| ATE366045T1 (de) * | 2002-03-15 | 2007-07-15 | Ciba Sc Holding Ag | Verwendung von 4-aminopyrimidinen zur antimikrobiellen behandlung von oberflächen |
| US20040009981A1 (en) | 2002-03-15 | 2004-01-15 | David Bebbington | Compositions useful as inhibitors of protein kinases |
| MY141867A (en) | 2002-06-20 | 2010-07-16 | Vertex Pharma | Substituted pyrimidines useful as protein kinase inhibitors |
| CN101037438A (zh) | 2002-08-02 | 2007-09-19 | 沃泰克斯药物股份有限公司 | 用作gsk－3的抑制剂的吡唑组合物 |
| WO2004072029A2 (en) | 2003-02-06 | 2004-08-26 | Vertex Pharmaceuticals Incorporated | Pyrazolopyridazines useful as inhibitors of protein kinases |
| EP1917259B1 (en) | 2005-08-18 | 2012-01-25 | Vertex Pharmaceuticals Incorporated | Pyrazine kinase inhibitors |
| SG166827A1 (en) | 2005-11-03 | 2010-12-29 | Vertex Pharma | Aminopyrimidines useful as kinase inhibitors |
| MX2009004807A (es) | 2006-11-02 | 2009-06-15 | Vertex Pharma | Aminopiridinas y aminopirimidinas utiles como inhibidores de proteina cinasa. |
| DE602007007985D1 (de) | 2006-12-19 | 2010-09-02 | Vertex Pharma | Als inhibitoren von proteinkinasen geeignete aminopyrimidine |
| CN101663295B (zh) | 2007-03-09 | 2014-11-05 | 沃泰克斯药物股份有限公司 | 可用作蛋白激酶抑制剂的氨基嘧啶类化合物 |
| MX2009009591A (es) | 2007-03-09 | 2009-11-10 | Vertex Pharma | Aminopirimidinas utiles como inhibidores de proteinas cinasas. |
| MX2009009592A (es) | 2007-03-09 | 2009-11-10 | Vertex Pharma | Aminopiridinas utiles como inhibidores de proteinas cinasas. |
| CN101679386A (zh) | 2007-04-13 | 2010-03-24 | 沃泰克斯药物股份有限公司 | 可用作激酶抑制剂的氨基嘧啶类化合物 |
| WO2008137621A1 (en) | 2007-05-02 | 2008-11-13 | Vertex Pharmaceuticals Incorporated | Aminopyrimidines useful as kinase inhibitors |
| EP2152694A2 (en) | 2007-05-02 | 2010-02-17 | Vertex Pharmaceuticals Incorporated | Thiazoles and pyrazoles useful as kinase inhibitors |
| CA2694499A1 (en) | 2007-07-31 | 2009-02-05 | Vertex Pharmaceuticals Incorporated | Process for preparing 5-fluoro-1h-pyrazolo [3, 4-b] pyridin-3-amine and derivatives thereof |
| JP2012501971A (ja) | 2008-09-03 | 2012-01-26 | バーテックス ファーマシューティカルズ インコーポレイテッド | 共結晶および共結晶を含む薬学的処方物 |
| UY32306A (es) * | 2008-12-09 | 2010-07-30 | Gilead Sciences Inc | Derivados de pteridinona y pirimidinodiazepinona y composiciones farmacéuticas que modulan en forma selectiva los receptores tipo toll, métodos y usos |
| KR102328682B1 (ko) | 2018-08-27 | 2021-11-18 | 주식회사 대웅제약 | 신규한 헤테로사이클릭아민 유도체 및 이를 포함하는 약학 조성물 |
| EP4243826A1 (en) * | 2020-11-12 | 2023-09-20 | 3Z Ehf | Novel treatments of attention deficit/hyperactivity disorder |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE754832A (fr) * | 1969-08-14 | 1971-02-15 | Beecham Group Ltd | Iminazolines |
-
1980
- 1980-05-05 MA MA19025A patent/MA18829A1/fr unknown
- 1980-05-13 DD DD80221082A patent/DD150609A5/de unknown
- 1980-05-14 ES ES491514A patent/ES491514A0/es active Granted
- 1980-05-15 NZ NZ193730A patent/NZ193730A/xx unknown
- 1980-05-15 IL IL60086A patent/IL60086A/xx unknown
- 1980-05-16 NO NO801469A patent/NO801469L/no unknown
- 1980-05-16 GB GB8016309A patent/GB2052487B/en not_active Expired
- 1980-05-16 AU AU58484/80A patent/AU5848480A/en not_active Abandoned
- 1980-05-16 IE IE1023/80A patent/IE49803B1/en unknown
- 1980-05-16 ZW ZW118/80A patent/ZW11880A1/xx unknown
- 1980-05-16 ZA ZA00802909A patent/ZA802909B/xx unknown
- 1980-05-16 EP EP80102724A patent/EP0019811A1/de not_active Withdrawn
- 1980-05-16 DK DK214480A patent/DK214480A/da not_active Application Discontinuation
- 1980-05-16 PT PT71251A patent/PT71251A/pt unknown
- 1980-05-16 GR GR61963A patent/GR68453B/el unknown
- 1980-05-16 FI FI801600A patent/FI801600A7/fi not_active Application Discontinuation
- 1980-05-17 PL PL22431380A patent/PL224313A1/xx unknown
- 1980-05-17 OA OA57113A patent/OA06533A/xx unknown
- 1980-05-17 JP JP6586380A patent/JPS55154971A/ja active Pending
- 1980-05-17 KR KR1019800001944A patent/KR830002757A/ko active Pending
- 1980-05-19 AR AR281109A patent/AR228256A1/es active
Also Published As
| Publication number | Publication date |
|---|---|
| JPS55154971A (en) | 1980-12-02 |
| ES8104279A1 (es) | 1981-04-16 |
| IL60086A0 (en) | 1980-07-31 |
| IE801023L (en) | 1980-11-18 |
| MA18829A1 (fr) | 1980-12-31 |
| IE49803B1 (en) | 1985-12-25 |
| FI801600A7 (fi) | 1981-01-01 |
| GB2052487B (en) | 1983-05-11 |
| OA06533A (fr) | 1981-07-31 |
| EP0019811A1 (de) | 1980-12-10 |
| ZW11880A1 (en) | 1980-12-17 |
| PT71251A (en) | 1980-06-01 |
| DK214480A (da) | 1980-11-19 |
| PL224313A1 (es) | 1981-02-13 |
| AU5848480A (en) | 1980-11-20 |
| NZ193730A (en) | 1982-12-21 |
| ZA802909B (en) | 1981-05-27 |
| IL60086A (en) | 1984-03-30 |
| GB2052487A (en) | 1981-01-28 |
| GR68453B (es) | 1981-12-30 |
| DD150609A5 (de) | 1981-09-09 |
| KR830002757A (ko) | 1983-05-30 |
| NO801469L (no) | 1980-11-19 |
| ES491514A0 (es) | 1981-04-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR228256A1 (es) | Procedimiento para la elaboracion de nuevos compuestos de 2-(pirimidinilamino)-1,3-diaza-2-cicloalqueno | |
| ES514585A0 (es) | Procedimiento para la obtencion de derivados de oxazol trisustituidos. | |
| AR224008A1 (es) | Procedimiento para preparar polihidro-3,7-dimetil-8-(2-(tetrahidro-4-hidroxi-6-oxo-2h-piran-2-il)-etil)-1-naftil-2-metilbutirato | |
| ES535946A0 (es) | Procedimiento para preparar 2-(2-benzoil sustituido)-1, 3-ciclohexanodionas | |
| ES488196A0 (es) | Procedimiento para la preparacion de compuestos de dioxacinabasicos | |
| AR230437A1 (es) | Procedimiento para la fabricacion de derivados de 2-(dialquamino,pirrolidinil o piperidinil)-alquil-tio-quinolina | |
| AR227527A1 (es) | Procedimiento para la elaboracion de nuevos compuestos n-oxaciclilalquil-piperidil-diazoicos | |
| ES493846A0 (es) | Un procedimiento para la preparacion de nuevos compuestos oligolipidos. | |
| ES497366A0 (es) | Un procedimiento para la preparacion de nuevos compuestos de mercaptoorganosiloxano. | |
| ES491341A0 (es) | Procedimiento para la obtencion de derivados fluorados de triazolil-butano, de efecto fungicida | |
| AR227286A1 (es) | Procedimiento para la elaboracion de nuevos compuestos de 1-(2-imidazolidin-1-ilo-alquil)-3-fenilurea o tiourea | |
| ES489689A0 (es) | Procedimiento para preparar compuestos de isotiourea | |
| MX6580E (es) | Procedimiento para la preparacion de compuestos acetoximetil-penam | |
| ES493499A0 (es) | Procedimiento para preparar compuestos de 3-metilemazetidina | |
| AR213659A1 (es) | Procedimiento para la preparacion de 2-(4-(aroil o heteroaroil)-piperazin-1-il)-4-amino-6,7-dimetoxiquinazolinas | |
| AR224318A1 (es) | Procedimiento para la preparacion de compuestos de piran-4-ona | |
| ES488709A0 (es) | Procedimiento para la preparacion de compuestos diorganomag-nesicos,r2mg | |
| AR223319A1 (es) | Procedimiento para la elaboracion de compuestos de 6-amino-penam | |
| ES493016A0 (es) | Procedimiento para la preparacion de nuevas 2-(perhi- dro-1,4-diazino)-pirimido(5,4-d)pirimidinas | |
| ES494211A0 (es) | Procedimiento para la preparacion de nuevos derivados de 10-halogen-e-homo-eburnanos. | |
| AR228330A1 (es) | Procedimiento para la preparacion de nuevas 4-(3-trifluormetilfenil)-1,2,3,6-tetrahidropiridinas | |
| AR216675A1 (es) | Procedimiento para la preparacion de 2-(gamma-(1-piperidinil)propil)-1,2-benzisotiazol-3-ona | |
| ES496509A0 (es) | Procedimiento para la preparacion de nuevos compuestos ca- tionicos | |
| MX5101E (es) | Procedimiento para la preparacion de 2-(2',2',2',-trihalogenoetil)-4-halogenociclobutan-1-onas | |
| ES492672A0 (es) | Procedimiento para la preparacion de compuestos de nitroari-lo substituidos |